
Site burden is now measured through satisfaction surveys, in-the-moment check-ins, and adoption patterns, but each method catches a different moment, and the gaps between them decide whether teams can act before burden becomes risk.
Catalent Pharma Solutions announced that it is investing $5.5 million at its 200,000+ square foot Philadelphia, Pennsylvania site to provide additional clinical packaging and storage capacity. This provider of technologies and development solutions for drugs, biologics and consumer health products is looking to expand their Philadelphia location with many different advances.
Read the full release






